<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for DEPO</title>
    <link />
    <description>Headlines for DepoMed, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Biotech Value Investments For 2013 With No Approval Risk</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/plcsf/articles/191461/biotech-value-investments-for-2013-with-no-approval-risk/2013-06-12.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Wed, 12 Jun 2013 17:10:09 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130603-000162&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Mon, 03 Jun 2013 09:02:59 GMT</pubDate>
    </item>
    <item>
      <title>Stocks to Buy: Biotechs With Binary Events</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/31/stocks-to-buy-biotechs-with-binary-events/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 31 May 2013 13:46:00 GMT</pubDate>
    </item>
    <item>
      <title>After Hours Most Active for May 20, 2013 :  QQQ, SID, GGB, PBR, OZM, MSFT, APO, AAPL, BAC, RFMD, MYL</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/after-hours-most-active-for-may-20-2013-qqq-sid-ggb-pbr-ozm-msft-apo-aapl-bac-rfmd-myl-depo-cm247330.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 20 May 2013 16:43:15 GMT</pubDate>
    </item>
    <item>
      <title>DepoMed Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1416691-depomed-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 20:10:07 GMT</pubDate>
    </item>
    <item>
      <title>Short Interest In DepoMed Moves 11% Lower</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11906344/1/short-interest-in-depomed-moves-11-lower.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 25 Apr 2013 16:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Following The Crashing Biotechs - 4 Stocks Ready For Spring</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1326101-following-the-crashing-biotechs-4-stocks-ready-for-spring.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 04:45:59 GMT</pubDate>
    </item>
    <item>
      <title>Bio Run Ups: What To Expect In The Next Few Months</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1294581-bio-run-ups-what-to-expect-in-the-next-few-months.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 22 Mar 2013 06:23:49 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/09/this-week-in-biotech-18/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 09 Mar 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Buyout Speculation Drives Up Theravance Ahead Of FDA Advisory Committee Meeting</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1253861-buyout-speculation-drives-up-theravance-ahead-of-fda-advisory-committee-meeting.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Mar 2013 19:31:45 GMT</pubDate>
    </item>
    <item>
      <title>Why Depomed Isn't Worth the Risk</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/06/why-depomed-isnt-worth-the-risk/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 06 Mar 2013 18:03:00 GMT</pubDate>
    </item>
    <item>
      <title>FDA Panel Kills Sefelsa, Creates Buying Opportunity In Depomed Stock</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1247141-fda-panel-kills-sefelsa-creates-buying-opportunity-in-depomed-stock.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 05 Mar 2013 09:37:25 GMT</pubDate>
    </item>
    <item>
      <title>Why DepoMed Shares Crashed</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/04/why-depomed-shares-crashed/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 04 Mar 2013 15:58:00 GMT</pubDate>
    </item>
    <item>
      <title>Depomed Will Cease All Spending on Sefelsa</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3387278/depomed-will-cease-all-spending-on-sefelsa.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 04 Mar 2013 13:35:12 GMT</pubDate>
    </item>
    <item>
      <title>Depomed FDA Panel Live Blog</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11857076/1/depomed-fda-panel-live-blog.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 04 Mar 2013 07:44:00 GMT</pubDate>
    </item>
    <item>
      <title>4 Can't-Miss Health-Care Events This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/03/4-cant-miss-health-care-events-this-week-3/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 03 Mar 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Roth Capital's Henry Sees Upcoming FDA Panel For Depomed's Sefelsa As A Coin Flip</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1241651-roth-capital-s-henry-sees-upcoming-fda-panel-for-depomed-s-sefelsa-as-a-coin-flip.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 01 Mar 2013 17:48:07 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: Ziopharm, Oncolytics, Sarepta</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11855905/1/biotech-stock-mailbag-ziopharm-oncolytics-sarepta.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 01 Mar 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Depomed Inc. Stock Upgraded (DEPO)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11849277/1/depomed-inc-stock-upgraded-depo.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 22 Feb 2013 04:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Fool Checkup: DepoMed Earnings</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/fool-checkup-depomed-earnings/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Feb 2013 13:04:58 GMT</pubDate>
    </item>
  </channel>
</rss>
